CMAC National Facility
Advanced capability for translational medicines manufacturing
Located within the University of Strathclyde, CMAC’s National Facility is a purpose-built 900m2 environment providing open access to future-ready technologies, specialist expertise, and integrated digital systems designed to accelerate end-to-end drug development and manufacturing.
-
CMAC’s National Facility is a leading centre for medicines manufacturing research and innovation. We provide access to capabilities, collaborative programmes and specialist expertise to accelerate digital, sustainable and patient-focused pharmaceutical development and production.
-
We deliver agile, data‑driven solutions through advanced facilities, integrated digital tools and specialist expertise, providing flexible, end‑to‑end support that accelerates high‑quality, efficient medicines development.
-
We collaborate with organisations of all sizes, academic institutions, technology developers and innovation partners.
Transforming medicines development from molecule to market
We deliver agile, data-driven R&D supporting discovery, particle engineering, crystallisation, formulation development, continuous drug product manufacturing and advanced analytics.
Our approach integrates digital CMC principles, including real-time data capture, model-informed development, AI/ML tools and connected knowledge graph infrastructures. These elements allow our capabilities, technical knowledge and expertise to transition laboratory concepts into industrially relevant processes that support faster, safer and more flexible medicines manufacturing.
Core capabilities
-
Supporting discovery, drug substance and drug product development, scale-up and advanced analytics.
-
Integrated digital CMC environments, real-time PAT, modelling and data-driven workflows.
-
Targeted analytical, modelling and process-design grounded in digital CMC, enabling predictive control and accelerated process understanding.
Engagement pathways
-
End-to-end R&D for complex pharmaceutical development challenges.
-
Hands-on use of our technology platforms with expert technical support.
-
Targeted analytics, modelling, troubleshooting and specialist expertise on demand.
Our research and consultancy services span the full development pipeline:
-
X-Ray and Solid State
-
Drug Product
-
Crystallisation
-
Nanomedicine
-
Analytics
Why work with CMAC?
Industry-aligned research: Our work is co-created with global pharmaceutical partners and directly aligned to industry need.
Accelerated development: Our streamlined, data-driven workflows and digital tools get you to market faster.
End-to-end support: Access integrated services across drug substance, drug product, and analytics.
Flexible access: Engage with us on your terms, whether it's full project delivery, technical consultancy, or one-off support.
Proven success: We have a strong track record of solving complex industrial challenges with global pharmaceutical partners.
Multidisciplinary expertise: Chemistry, pharmaceutics, engineering, analytics and process modelling experts integrated under one facility.
From molecule to market customer stories
Discovery to Particle Engineering:
“CMAC’s particle engineering support accelerated our API readiness, giving us material suitable for continuous processing far earlier than expected.”
— Former CustomerFormulation & Continuous Processing:
“The continuous direct compression expertise at CMAC significantly improved our material performance and reduced development cycle times.”
— Former CustomerDigital CMC & Analytics:
“The digital workflows and model‑informed approaches helped us identify optimal operating conditions with far fewer experiments.”
— Former CustomerCase Studies
Explore how our work has helped partners overcome development roadblocks and deliver better medicines.
